ArticleThe Journal of pharmacology and experimental therapeutics2025

Acid ceramidase as a novel target for adiponectin receptor agonist to abrogate podocyte NLRP3 inflammasome activation and glomerular inflammation during obesity.

Guangbi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.